| 1 |
35133094 | The Prediction of HER2-Targeted Treatment Response Using 64Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report. | 2022 Feb |
1 |
| 2 |
29502411 | Evaluation of an Anti-HER2 Nanobody Labeled with 225Ac for Targeted α-Particle Therapy of Cancer. | 2018 Apr 2 |
1 |
| 3 |
29116215 | Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m. | 2017 Nov 7 |
1 |
| 4 |
24337604 | Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET. | 2014 Jan |
3 |
| 5 |
24029656 | 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer. | 2013 Nov |
2 |
| 6 |
22519915 | DOTAGA-trastuzumab. A new antibody conjugate targeting HER2/Neu antigen for diagnostic purposes. | 2012 Jun 20 |
1 |
| 7 |
22768790 | Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules. | 2012 Aug 15 |
9 |
| 8 |
20219072 | Imaging and biodistribution of Her2/neu expression in non-small cell lung cancer xenografts with Cu-labeled trastuzumab PET. | 2010 Apr |
3 |
| 9 |
20885893 | Detection of Cancer Metastases with a Dual-labeled Near-Infrared/Positron Emission Tomography Imaging Agent. | 2010 Oct 1 |
1 |
| 10 |
17203203 | Labelling chemistry and characterization of [90Y/177Lu]-DOTA-ZHER2:342-3 Affibody molecule, a candidate agent for locoregional treatment of urinary bladder carcinoma. | 2007 Feb |
1 |
| 11 |
17671747 | Pre-clinical evaluation of [111In]-benzyl-DOTA-Z(HER2:342), a potential agent for imaging of HER2 expression in malignant tumors. | 2007 Sep |
1 |
| 12 |
21086574 | 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-synthetic HER2 specific Affibody ZHER2:342-pep2 | 2004 |
1 |
| 13 |
21882407 | 111In-Labeled DOTA-conjugated 6-aminohexanoic linker-containing variant of anti-epidermal growth factor receptor 2 Affibody ZHER2:342 (ABY-003) | 2004 |
3 |
| 14 |
23256220 | 68Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-HER2-specific Affibody ZHER2:2891 | 2004 |
1 |
| 15 |
23638490 | 111In-Labeled anti-epidermal growth factor receptor Affibody PEP09239 | 2004 |
1 |
| 16 |
10821648 | Biodistribution and radioimmunotherapy of human breast cancer xenografts with radiometal-labeled DOTA conjugated anti-HER2/neu antibody 4D5. | 2000 May-Jun |
1 |